Stocktoria
GALECTIN THERAPEUTICS INC GALT
Nasdaq · XNAS · stock · Pharmaceutical Preparations · website · IPO 2002-09-04
GALECTIN THERAPEUTICS INC statistics & valuation
Market cap$328.6M
Market cap as of 2026-06-29. Multiples are price-derived and refreshed daily; everything else is from filings.
Key ratios (by fiscal year)
| Ratio | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Return on assets | -157.9% | -268.9% | -145.6% | -182.2% | -73.0% |
| Return on equity | 24.1% | 44.9% | 66.3% | 114.3% | -3418.5% |
| Current ratio | 2.42 | 0.49 | 1.77 | 1.58 | 4.63 |
Source: SEC EDGAR filings · CIK 0001133416 · as of 2025-12-31. Facts from filings plus Stocktoria's own computed scores — not investment advice.